Lassila, Markus <br/><br/>
Imatinib attenuates diabetic nephropathy in apolipoprotein E-knockout mice.  [electronic resource] 

 -  Journal of the American Society of Nephrology : JASN  Feb 2005 
 - 363-73 p.  digital 
<br/><br/> Publication Type: Comparative Study; Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1046-6673 
<br/><br/><label>Standard No.: </label>10.1681/ASN.2004050392  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Apolipoproteins E<br/>Base Sequence<br/>Benzamides<br/>Biopsy, Needle<br/>Diabetic Nephropathies--drug therapy<br/>Disease Models, Animal<br/>Gene Expression Regulation<br/>Imatinib Mesylate<br/>Immunohistochemistry<br/>Kidney Function Tests<br/>Male<br/>Mice<br/>Mice, Knockout<br/>Molecular Sequence Data<br/>Piperazines--pharmacology<br/>Pyrimidines--pharmacology<br/>Receptor, Platelet-Derived Growth Factor beta--drug effects<br/>Reference Values<br/>Reverse Transcriptase Polymerase Chain Reaction<br/>Sensitivity and Specificity<br/>Transforming Growth Factor beta--drug effects